xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

692

International consensus statement on rhinosinusitis

intensive medical treatment for chronic sinusitis. AmJRhinol . 2002;16(6):303-312. 1097. Ikeda K, Sakurada T, Suzaki Y, Takasaka T. Efficacy of sys temic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology . 1995;33(3):162-165. 1098. Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am . 2010;43(4):753-768. 1099. Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corti costeroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol . 2018;141(1):110-116. e117. 1100. Gehanno P, Cohen B. Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients. Eur Arch Otorhinolaryngol . 1993;250(Suppl 1):S13-S14. 1101. Dellamonica P, Choutet P, Lejeune JM, et al. Efficacy and tol erance of cefotiam hexetil in the super-infected chronic sinusi tis. A randomized, double-blind study in comparison with cefixime. Ann Otolaryngol Chir Cervicofac . 1994;111(4):217-222. 1102. Huck W, Reed BD, Nielsen RW, et al. Cefaclor vs amoxicillin in the treatment of acute, recurrent, and chronic sinusitis. Arch Fam Med . 1993;2(5):497-503. 1103. Legent F, Bordure P, Beauvillain C, Berche P. A double blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy . 1994;40(Suppl 1):8-15. 1104. Namyslowski G, Misiolek M, Czecior E, et al. Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother . 2002;14(5):508-517. 1105. Head K, Chong LY, Piromchai P, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev . 2016;4:CD011994. 1106. Poetker DM, Smith TL. What rhinologists and allergists should know about the medico-legal implications of antibi otic use: a review of the literature. Int Forum Allergy Rhinol . 2015;5(2):104-110. 1107. McNally PA, White MV, Kaliner MA. Sinusitis in an allergist’s office: analysis of 200 consecutive cases. Allergy Asthma Proc . 1997;18(3):169-175. 1108. Dubin MG, Kuhn FA, Melroy CT. Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics. Ann Allergy Asthma Immunol . 2007;98(1):32-35. 1109. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosi nusitis. Rhinology . 2007;45(4):259-267. 1110. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryn goscope . 2006;116(2):189-193. 1111. Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long term, low-dose azithromycin in chronic rhinosinusitis: a ran domized controlled trial. Allergy . 2011;66(11):1457-1468. 1112. Jiang RS, Wu SH, Tsai CC, Li YH, Liang KL. Efficacy of Chi nese herbal medicine compared with a macrolide in the treat ment of chronic rhinosinusitis without nasal polyps. AmJRhi nol Allergy . 2012;26(4):293-297. 1113. Majima Y, Kurono Y, Hirakawa K, et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and

for chronic eosinophilic sinusitis. J Allergy Clin Immunol . 2009;124(6):1352-1354.e1357. 1082. Welch KC, Thaler ER, Doghramji LL, Palmer JN, Chiu AG. The effects of serum and urinary cortisol levels of topi cal intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery. Am J Rhinol Allergy . 2010;24(1):26-28. 1083. Bhalla RK, Payton K, Wright ED. Safety of budesonide in saline sinonasal irrigations in the management of chronic rhi nosinusitis with polyposis: lack of significant adrenal suppres sion. J Otolaryngol Head Neck Surg . 2008;37(6):821-825. 1084. Sher MR, Steven GC, Romett JL, et al. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps. Rhinology . 2020;58(1):25-35. 1085. Palmer JN, Jacobson KW, Messina JC, Kosik-Gonzalez C, Djupesland PG, Mahmoud RA. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS FLU) in chronic rhinosinusitis. Int Forum Allergy Rhinol . 2018;8(8):869-876. 1086. Thamboo A, Manji J, Szeitz A, et al. The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis. Int Forum Allergy Rhinol . 2014;4(5):397-402. 1087. Manji J, Singh G, Okpaleke C, et al. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis. Int Forum Allergy Rhinol . 2017;7(5):488-493. 1088. Moshaver A, Velazquez-Villasenor L, Lavigne F, Witterick IJ. Selective irrigation of paranasal sinuses in the treat ment of recalcitrant chronic sinusitis. Am J Rhinol Allergy . 2010;24(5):371-373. 1089. Grayson JW, Harvey RJ. Topical corticosteroid irriga tions in chronic rhinosinusitis. Int Forum Allergy Rhinol . 2019;9(S1):S9-s15. 1090. Liu YF, Richardson CM, Bernard SH, Church CA, Seiberling KA. Antibiotics, steroids, and combination therapy in chronic rhinosinusitis without nasal polyps in adults. Ear, Nose Throat J . 2018;97(6):167-172. 1091. Poetker DM, Jakubowski LA, Lal D, Hwang PH, Wright ED, Smith TL. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol . 2013;3(2):104-120. 1092. Young LC, Stow NW, Zhou L, Douglas RG. Efficacy of medical therapy in treatment of chronic rhinosinusitis. Allergy Rhinol (Providence) . 2012;3(1):e8-e12. 1093. Lal D, Hwang PH. Oral corticosteroid therapy in chronic rhi nosinusitis without polyposis: a systematic review. Int Forum Allergy Rhinol . 2011;1(2):136-143. 1094. Lal D, Scianna JM, Stankiewicz JA. Efficacy of targeted medi cal therapy in chronic rhinosinusitis, and predictors of failure. Am J Rhinol Allergy . 2009;23(4):396-400. 1095. Hessler JL, Piccirillo JF, Fang D, et al. Clinical outcomes of chronic rhinosinusitis in response to medical therapy: results of a prospective study. AmJRhinol . 2007;21(1):10-18. 1096. Subramanian HN, Schechtman KB, Hamilos DL. A retrospec tive analysis of treatment outcomes and time to relapse after